Theravance (THRX +1%) moves up this morning after the stock was halted in after hours trading yesterday on news that the Anti-Infective Drugs Advisory Committee of the FDA has given a favorable response for its antibiotic Vibativ, a for the treatment of nosocomial pneumonia.
Theravance (THRX +1%) moves up this morning after the stock was halted in after hours trading...
From other sites
at CNBC.com (Jun 11, 2014)
at CNBC.com (Dec 6, 2013)
at CNBC.com (Sep 10, 2013)
at CNBC.com (Jun 24, 2013)
at CNBC.com (Apr 15, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs